ROCK1 and glioma: Here, we found that miR-584 was up-regulated in ATC, while it is down-regulated in glioma, where it suppress cell growth [41]; in renal cell carcinoma, where it targets ROCK1 to decrease invasion [42]; and in breast carcinoma [43].